Breaking News Instant updates and real-time market news.

CVS

CVS Health

$68.70

-0.31 (-0.45%)

, AET

Aetna

$177.12

0.05 (0.03%)

10:45
03/13/18
03/13
10:45
03/13/18
10:45

Aetna to host special shareholder meeting

Special Shareholder Meeting to vote on the merger with CVS will be held in New York on March 13 at 11 am.

CVS

CVS Health

$68.70

-0.31 (-0.45%)

AET

Aetna

$177.12

0.05 (0.03%)

  • 13

    Mar

  • 13

    Mar

  • 16

    Apr

  • 30

    May

CVS CVS Health
$68.70

-0.31 (-0.45%)

03/08/18
JEFF
03/08/18
NO CHANGE
Target $91
JEFF
Buy
Jefferies does not expect competing bids for Express Scripts
Jefferies analyst Brian Tanquilut believes Cigna (CI) is paying a fair price for Express Scripts (ESRX) and does not expect competing bids to emerge. The deal is another mark on the ongoing vertical integration wave in Healthcare, Tanquilut tells investors in a research note. The analyst previously stated that Express Script would be the most logical acquisition target for Amazon (AMZN) if the tech giant truly had aspirations of entering the pharmacy retailing market. However, it appears that speculation has quieted down in recent weeks, Tanquilut admits today. Regarding regulatory risk for the Cigna/Express Scripts deal, the analyst believes scrutiny will come mostly from the government's interest in what a large-scale combination of large players from two different healthcare sub-sectors will bring to overall drug costs, patient premiums and out-of-pocket dollars. He highlights the existence of UnitedHealth's (UNH) OptumRx and CVS's (CVS) Caremark. Cigna in morning trading is down 9.5%, or $18.47, to $175.75 while Express Scripts is up 11% to $81.59.
02/27/18
BOFA
02/27/18
INITIATION
Target $91
BOFA
Buy
CVS Health reinstated with a Buy at BofA/Merrill
BofA/Merrill analyst Michael Cherny reinstated coverage on CVS Health with a Buy and $91 price target.
02/14/18
JEFF
02/14/18
NO CHANGE
JEFF
Amazon focusing on bolstering medical device distribution, says Jefferies
Yesterday's Wall Street Journal report and a recent scan of job postings still point to Amazon.com's (AMZN) focus on bolstering its medical device/supplies distribution capabilities, specifically targeting hospitals, Jefferies analyst Brian Tanquilut. These postings support a negative thesis for Cardinal Health (CAH), Owens & Minor (OMI) and Premier's (PINC) medical supplies businesses, the analyst adds. Further, he sees the news as an incremental positive for AmerisourceBergen (ABC), McKesson (MCK), CVS Health (CVS) and Walgreens Boots Alliance (WBA) since it further supports the view that Amazon isn't looking to enter the prescription business near-term.
02/09/18
NEED
02/09/18
NO CHANGE
Target $98
NEED
Strong Buy
CVS Health price target lowered to $98 after earnings at Needham
Needham analyst Kevin Caliendo lowered his price target on CVS Health to $98 from $100 after the company's earnings. Caliendo notes that while the PBM and retail businesses were solid, the negative development of CVS planning to reinvest $1.2B of tax reform windfall in compensation and infrastructure "undermined the positives". The analyst is also concerned with President Trump's budget proposal focusing on curbing drug prices. However, he maintains a Strong Buy rating on CVS shares.
AET Aetna
$177.12

0.05 (0.03%)

02/01/18
02/01/18
DOWNGRADE
Target $69

Underperform
Express Scripts downgraded to Underperform at Bernstein
As previously reported, Bernstein analyst Lance Wilkes downgraded Express Scripts to Underperform from Market Perform, with a $69 price target, as he believes tax reform is fully price in and his original concerns on the standalone PBM model remain. Further, the analyst sees additional risks from a potential CVS (CVS)/Aetna (AET) merger and Amazon (AMZN) threats.
01/31/18
FBCO
01/31/18
NO CHANGE
Target $208
FBCO
Neutral
Aetna price target raised to $208 from $200 at Credit Suisse
Credit Suisse analyst A.J. Rice raised his price target for Aetna to $208 from $200, citing on track operationally. However, the analyst is cautious on sustainability of tax benefit. He reiterates a Neutral rating on the shares.
01/31/18
RBCM
01/31/18
UPGRADE
Target $98
RBCM
Outperform
Express Scripts upgraded to Outperform at RBC Capital
As reported earlier, RBC Capital analyst George Hill upgraded Express Scripts (ESRX) to Outperform and raised his price target to $98 from $68. Hill cites the "recent sharp pullback on Amazon's (AMZN) healthcare entry" de-risking the stock, while also pointing to the trend of vertical integration as seen in the CVS (CVS)-Aetna (AET) deal. The analyst believes Express Scripts could also become an attractive M&A target as "one of the few remaining assets at scale".
01/31/18
PIPR
01/31/18
NO CHANGE
Target $212
PIPR
Overweight
Piper sees buying opportunity in Aetna after yesterday's pullback
Piper Jaffray analyst Sarah James sees a buying opportunity in Aetna (AET) following yesterday's 3% pullback on the Amazon (AMZN), Berkshire (BRK.A) and JPMorgan (JPM) news. The company yesterday morning posted a solid earnings beat driven by strong cost trend management in the government and commercial businesses, James tells investors in a research note. She raised her price target for Aetna shares to $212 from $207 and keeps an Overweight rating on the name. CVS Health's (CVS) takeout offer now values the shares at $212, up from $207 previously, based on 0.8378 shares of CVS stock plus $145 per share in cash, James points out. The analyst sees a "win-win" setup for the stock based on the deal going through or the company remaining standalone.

TODAY'S FREE FLY STORIES

MTCH

Match Group

$41.98

0.93 (2.27%)

16:15
12/18/18
12/18
16:15
12/18/18
16:15
Initiation
Match Group initiated  »

Match Group initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INAP

Internap

$3.99

-0.14 (-3.39%)

16:12
12/18/18
12/18
16:12
12/18/18
16:12
Earnings
Internap narrows FY18 revenue view to $320M-$324M from $320M-$330M »

Consensus $322,32M. Sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSTI

ShotSpotter

$29.26

-0.02 (-0.07%)

16:12
12/18/18
12/18
16:12
12/18/18
16:12
Initiation
ShotSpotter initiated  »

ShotSpotter initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCS

Steelcase

$14.28

0.11 (0.78%)

16:10
12/18/18
12/18
16:10
12/18/18
16:10
Earnings
Steelcase sees Q4 EPS 24c-28c, consensus 26c »

Sees Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

UPS

UPS

$97.72

0.8 (0.83%)

, FDX

FedEx

$185.74

3.54 (1.94%)

16:09
12/18/18
12/18
16:09
12/18/18
16:09
Hot Stocks
FedEx slides after cutting outlook citing European weakness, UPS follows »

In after-hours trading,…

UPS

UPS

$97.72

0.8 (0.83%)

FDX

FedEx

$185.74

3.54 (1.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

HTGM

HTG Molecular

$2.40

-0.3 (-11.11%)

16:09
12/18/18
12/18
16:09
12/18/18
16:09
Hot Stocks
HTG Molecular establishes French unit to support expanding growth »

HTG Molecular Diagnostics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INAP

Internap

$3.98

-0.15 (-3.63%)

16:09
12/18/18
12/18
16:09
12/18/18
16:09
Earnings
Internap sees FY19 revenue $325M-$335M, consensus $340.09M »

Sees FY19 adjusted EBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HTGM

HTG Molecular

$2.40

-0.3 (-11.11%)

16:08
12/18/18
12/18
16:08
12/18/18
16:08
Hot Stocks
HTG Molecular establishes French unit to support expanding growth »

HTG Molecular Diagnostics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REI

Ring Energy

$5.18

0.02 (0.39%)

16:08
12/18/18
12/18
16:08
12/18/18
16:08
Hot Stocks
Ring Energy provides update on Q4 operations »

Ring Energy provided an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCS

Steelcase

$14.23

0.055 (0.39%)

16:07
12/18/18
12/18
16:07
12/18/18
16:07
Earnings
Steelcase reports Q3 adjusted EPS 36c, consensus 30c »

Reports Q3 revenue $901M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

FDX

FedEx

$185.82

3.62 (1.99%)

16:07
12/18/18
12/18
16:07
12/18/18
16:07
Earnings
FedEx sees FY19 EPS $15.50-$16.50, may not compare to $17.73 consensus »

Sees FY19 CAPEX of $5.6B.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

JBL

Jabil

$22.25

0.685 (3.18%)

16:07
12/18/18
12/18
16:07
12/18/18
16:07
Earnings
Jabil sees Q2 core EPS 51c-71c, consensus 61c »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

JBL

Jabil

$22.26

0.7 (3.25%)

16:06
12/18/18
12/18
16:06
12/18/18
16:06
Earnings
Jabil reports Q1 core EPS 90c, consensus 88c »

Reports Q1 revenue $6.5B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

SURF

Surface Oncology

$7.19

-0.6 (-7.70%)

16:06
12/18/18
12/18
16:06
12/18/18
16:06
Hot Stocks
Surface Oncology reduces scope for CD47 program, accelerates SRF388 IND »

Surface Oncology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FANG

Diamondback Energy

$88.44

-0.09 (-0.10%)

16:05
12/18/18
12/18
16:05
12/18/18
16:05
Hot Stocks
Diamondback Energy announces FY19 guidance, plans to boost annual dividend 50% »

Diamondback Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDX

FedEx

$185.80

3.6 (1.98%)

16:04
12/18/18
12/18
16:04
12/18/18
16:04
Hot Stocks
Breaking Hot Stocks news story on FedEx »

FedEx reports Q2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

MU

Micron

$34.45

0.56 (1.65%)

16:04
12/18/18
12/18
16:04
12/18/18
16:04
Earnings
Micron CEO bullish on memory, storage industry growth trends »

"Micron reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 08

    Jan

AIR

AAR Corp.

$42.46

2.71 (6.82%)

16:04
12/18/18
12/18
16:04
12/18/18
16:04
Earnings
AAR reports Q2 adjuted EPS 39c, consensus 57c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

FDX

FedEx

$185.38

3.18 (1.75%)

16:04
12/18/18
12/18
16:04
12/18/18
16:04
Earnings
FedEx reports Q2 adjusted EPS $4.03, consensus $3.94 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

CTIC

CTI BioPharma

$1.23

(0.00%)

16:03
12/18/18
12/18
16:03
12/18/18
16:03
Hot Stocks
CTI BioPharma receives input from FDA on pacritinib development »

CTI BioPharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIR

AAR Corp.

$42.46

2.71 (6.82%)

16:03
12/18/18
12/18
16:03
12/18/18
16:03
Earnings
Correction: AAR reports Q2 adjuted EPS 39c, consensus 57c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

MU

Micron

$34.47

0.58 (1.71%)

16:03
12/18/18
12/18
16:03
12/18/18
16:03
Earnings
Micron reports Q1 EPS $2.97, consensus $2.96 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 08

    Jan

GSAT

Globalstar

$0.36

0.0131 (3.74%)

16:02
12/18/18
12/18
16:02
12/18/18
16:02
Syndicate
Globalstar files to sell $60M in comon stock »

Cantor Fitzgerald &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SURF

Surface Oncology

$7.18

-0.61 (-7.83%)

16:00
12/18/18
12/18
16:00
12/18/18
16:00
Hot Stocks
Breaking Hot Stocks news story on Surface Oncology »

Surface Oncology Inc…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTDOY

Nintendo

$0.00

(0.00%)

15:58
12/18/18
12/18
15:58
12/18/18
15:58
Hot Stocks
Nintendo: NPD says Switch fastest-selling game console of this generation »

Nintendo said that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.